IDYA Dividend: IDEAYA Biosciences Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

IDYA Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	214	7	23	50	27	19
Revenue Growth (YoY)	7,033%	-70%	-54%	85%	42%	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	55	39	28	23	20	15
Research & Development	294	294	129	89	58	39
Operating Expenses	423	333	157	113	78	54
Other Non Operating Income (Expenses)	12	--	--	--	--	--
Pretax Income	-160	-274	-112	-58	-49	-34
Income Tax Expense	--	0	--	--	--	--
Net Income	-160	-274	-112	-58	-49	-34
Net Income Growth	-10%	145%	93%	18%	44%	-17%
Shares Outstanding (Diluted)	89.69	81.67	57.51	41.44	35.25	24.72
Shares Change (YoY)	4%	42%	39%	18%	43%	98%
EPS (Diluted)	-1.78	-3.36	-1.96	-1.42	-1.41	-1.4
EPS Growth	-14%	71%	38%	1%	1%	-57.99%
Free Cash Flow	-105	-251	-117	-90	-58	54
Free Cash Flow Per Share	-1.17	-3.07	-2.03	-2.17	-1.64	2.18
Gross Margin	--	--	--	--	--	--
Operating Margin	-97.66%	-4,657.14%	-582.6%	-124%	-185.18%	-184.21%
Profit Margin	-74.76%	-3,914.28%	-486.95%	-115.99%	-181.48%	-178.94%
Free Cash Flow Margin	-49.06%	-3,585.71%	-508.69%	-180%	-214.81%	284.21%
EBITDA	-207	-324	-132	-60	-49	-34
EBITDA Margin	-96.72%	-4,628.57%	-573.91%	-120%	-181.48%	-178.94%
D&A For EBITDA	2	2	2	2	1	1
EBIT	-209	-326	-134	-62	-50	-35
EBIT Margin	-97.66%	-4,657.14%	-582.6%	-124%	-185.18%	-184.21%
Effective Tax Rate	--	0%	--	--	--	--